The latest price of ibrutinib/ibrutinib in 2024

Ibrutinib/Ibrutinib is a targeted drug that has attracted much attention in recent years. It has demonstrated significant efficacy in the treatment of hematological malignancies. This drug is mainly used to treat various diseases such as mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), Waldenstrom's macroglobulinemia (WM), marginal zone lymphoma (MZL) and chronic graft-versus-host disease (cGVHD). Its unique mechanism of action allows ibrutinib to interfere with specific cancer cell signaling pathways, thereby inhibiting tumor growth and spread.

Recently, the original ibrutinib drug has been launched in capsule form in China and has been successfully included in the reimbursement scope of Class B medical insurance. This is undoubtedly a great benefit for the majority of patients, but it is worth noting that reimbursement services are limited to patients who meet the indication conditions. At present, the common specifications on the market are 140mg*90 capsules, and the price per box is about RMB 10,000.

At the same time, the price of the original ibrutinib drug in overseas markets appears to be even higher. Products with the same specifications may sell for more than $10,000 overseas. Fortunately, however, many countries overseas have begun producing and selling generic versions of ibrutinib. These generic drugs are almost identical in ingredients to the original drugs, but are more affordable. For example, the Bangladeshi, Indian and Lao versions of ibrutinib may cost only a few hundred to 1,000 yuan per box (the specific price may vary due to exchange rate fluctuations). For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.